Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
Shin JE, Kim SH, Kong M, Kim HR, Yoon S, Kee KM, Kim JA, Kim DH, Park SY, Park JH, Kim H, No KT, Lee HW, Gee HY, Hong S, Guan KL, Roe JS, Lee H, Kim DW, Park HW.
Shin JE, et al. Among authors: guan kl.
Mol Cancer. 2023 Nov 6;22(1):177. doi: 10.1186/s12943-023-01837-4.
Mol Cancer. 2023.
PMID: 37932786
Free PMC article.